David Kägi
University of Zurich
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David Kägi.
Immunological Reviews | 1995
David Kägi; Birgit Ledermann; Kurt Bürki; Rol F M. Zinkernagel; Hans Hengartner
Two classes of lymphocytes are able to exert contact-dependent cytotoxicity: cytotoxic T cells (CTL) react specifically against target cells presenting processed antigenic peptides on self MHC molecules whereas NK cells lyse a variety of target cells without classical restriction by MHC molecules. Although these two effector populations differ in specificity and lineage, the characteristics of their cytotoxic activity and some of their morphological aspects are remarkably similar (Henkart 1985). Because cytotoxicity is thought to be involved in a wide range of immune processes, the mechanisms accounting for lymphocyte-mediated cytotoxicity were studied intensively ever since cell-mediated cytolysis was first described (Govaertz 1960, Brunner et al. 1970). Important steps in the characterisation of cytolytic effector mechanisms were microscopic and microcinematographic studies showing that cytotoxic T cells form reversible conjugates with their target cells and secrete the content of their cytoplasmic granules during this process (Bykovskaja et al. 1978a,b, Matter 1979, Sanderson & Glauert 1979, Granger & Kolb 1968, Thiernesse et al. 1977, Zagury 1982), the isolation of perforin from granules of cytolytic lymphocytes and the demonstration that isolated perforin possess cytolytic activity in vitro (Podack et al. 1985. Young et al. I986a.b.c)., the observation of circular lesions on target cells lysed by lymphocytes (Dourmashkin et al. 1980, Dennert & Podack 1983) and the subsequent cloning of perforin (Shinkai et al. 1988, Lichtenheld et al. 1988) and other granule-associated proteins (Gershenfeld & Weissman 1986, Bleackley et al. 1988, Masson and
Placenta | 1998
Thomas Stallmach; Petra Arck; David Kägi; Thomas Rülicke
Summary Perforin is a cytotoxic molecule which is found in high concentration at the fetomaternal interface. In this location, perforin is contained in a specialized subset of natural killer cells, called uterine NK cells. By the use of perforin-deficient mice, we studied the function of perforin in the pregnant uterus. Perforin-deficient mice, we studied the function of perforin in the pregnant uterus. Perforin-deficient mice were found to reproduce as efficiently as wild type controls; however, they differed from normal in that the frequency of uterine NK cells was significantly higher and these cells were found to proliferate during more advanced stages of pregnancy. Lipopolysaccharide, which caused a massive increase of fetal resorptions in C57BL/6 control mice when given intraperitoneally on day 6.5 of pregnancy, had the same effect in the perforin-deficient counterpart. This argues against uterine NK cells being effector cells in infection-mediated abortion. Furthermore, no differences in fertility were observed under restricted mating conditions and with severe social stress. However, when embryo transfer was performed, the implantation of blastocysts was achieved in unprepared endometrium of perforin-deficient mice, which was not possible in wild type controls of the same genetic background. This could argue for a role of perforin in the defense of the mother against undue pregnancies.
Nature | 1994
David Kägi; Birgit Ledermann; Kurt Bürki; Peter Seiler; Bernhard Odermatt; Kristin J. Olsen; Eckhard R. Podack; Rolf M. Zinkernagel; Hans Hengartner
Science | 1994
David Kägi; Françoise Vignaux; Birgit Ledermann; Kurt Bürki; Valérie Depraetere; Shigekazu Nagata; Hans Hengartner; Pierre Golstein
Genes & Development | 1998
Minna Woo; Razqallah Hakem; Maria S. Soengas; Gordon S. Duncan; Arda Shahinian; David Kägi; Anne Hakem; Mila E. McCurrach; Wilson Khoo; Stephen Kaufman; Giorgio Senaldi; Tamara Howard; Scott W. Lowe; Tak W. Mak
Annual Review of Immunology | 1996
David Kägi; Birgit Ledermann; Kurt Bürki; Rolf M. Zinkernagel; Hans Hengartner
Journal of Experimental Medicine | 1996
M. F. Van Den Broek; David Kägi; F. Ossendorp; R. Toes; S. Vamvakas; W. K. Lutz; C. J. M. Melief; Rolf M. Zinkernagel; Hans Hengartner
European Journal of Immunology | 1995
David Kägi; Peter Seiler; Jovan Pavlovic; Birgit Ledermann; Kurt Bürki; Rolf M. Zinkernagel; Hans Hengartner
Journal of Experimental Medicine | 1999
Ursula Kapp; Wen-Chen Yeh; Bruce D. Patterson; Andrew J. Elia; David Kägi; Alexandra Ho; Andrew Hessel; Mike Tipsword; Alexia Williams; Christine Mirtsos; Annick Itie; Matthew Moyle; Tak W. Mak
Journal of Experimental Medicine | 1999
Jeanne Kehren; Cyril Desvignes; Maya Krasteva; Marie-Thérèse Ducluzeau; Olga Assossou; Françoise Horand; Michael Hahne; David Kägi; Dominique Kaiserlian; Jean-François Nicolas